Precision Medicine

  • Genetics and genomics study of endocrine disorders.
  • Using integrative omics to develop new drugs and health supplement.
  • Development of novel biomarker or prediction score for predicting clinical outcomes, such as incident disease, mortality, and treatment effectiveness (in endocrine disorders and cancer).
  • Evaluation of the effectiveness and safety of health supplement using randomized controlled trial, metabolomics, and animal study.
  • Pharmacogenomics of serious drug-related adverse events and treatment effectiveness.
Principal Investigators